<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52064">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02050230</url>
  </required_header>
  <id_info>
    <org_study_id>BASG 2013-002316-27</org_study_id>
    <secondary_id>2013-002316-27</secondary_id>
    <nct_id>NCT02050230</nct_id>
  </id_info>
  <brief_title>Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients</brief_title>
  <official_title>Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transfusion of stored blood has been associated with increased pulmonary vascular resistance
      in lambs. The investigators hypothesize that transfusion of one unit of red blood cells
      stored under standard conditions in intensive care patients will increase pulmonary arterial
      pressure and pulmonary vascular resistance to a greater extent than will one unit of fresh
      red blood cells.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pulmonary arterial pressure</measure>
    <time_frame>Change from baseline to immediately after transfusion (time frame of 20 min)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary vascular resistance</measure>
    <time_frame>Change from baseline to immediately after transfusion (time frame of 20 min)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic pressure</measure>
    <time_frame>Change from baseline to immediately after transfusion (time frame of 20 min)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic vascular resistance</measure>
    <time_frame>Change from baseline to immediately after transfusion (time frame of 20 min)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Fresh blood transfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One unit of blood stored for less than 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard issue blood transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One unit of blood stored under standard conditions</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood transfusion</intervention_name>
    <description>One unit of red blood cells will be transfused over the course of 20 minutes</description>
    <arm_group_label>Fresh blood transfusion</arm_group_label>
    <arm_group_label>Standard issue blood transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient has a pulmonary artery catheter in place

          2. Transfusion of 1 unit of packed red blood cells indicated for standard intensive care
             therapy

          3. The patient has an arterial catheter

        Exclusion Criteria:

          1. Age &lt; 18 years

          2. Clinical prediction that the patient will not survive at least 48 hours

          3. Acute bleeding: &gt; 2 units of packed red blood cells/hour

          4. Vasopressor use: noradrenalin &gt; 0.2 Î¼g/kg/min or any use of adrenalin within 6 hours
             of inclusion into the study

          5. Therapy with inhaled NO, inhaled prostacyclin, or phosphodiesterase-5-inhibitors

          6. Sepsis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roman Ullrich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David M Baron, MD</last_name>
    <phone>0043140400</phone>
    <phone_ext>4100</phone_ext>
    <email>david.baron@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>General Hospital of the Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David M Baron, MD</last_name>
    </contact>
    <investigator>
      <last_name>David M Baron, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roman Ullich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>January 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>David M Baron, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>transfusion</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>intensive care medicine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
